Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma
Dr. R. Willemze, W. G. Peters, M. B. van Hennik, W. E. Fibbe, A. M. M. Kootte, M. van Berkel, R. Lie, C. J. Rodenburg, J. J. VeltkampVolume:
34
Year:
1985
Language:
english
Pages:
5
DOI:
10.1111/j.1600-0609.1985.tb00748.x
File:
PDF, 314 KB
english, 1985